Yavuz Selim Silay

Chairman of Istanbul Consulting Group & Co-Founder of MAIN (MaQasid Angel Investors Network), Turkey

Title: The current trends in Bioentrepreneurship and Biotechnology Innovation Investments in USA, Europe, Turkey & Emerging Markets

---

Biography

Dr. Yavuz Selim Silay is the Chairman of Istanbul Consulting Group & Co-Founder of MAIN (MaQasid Angel Investors Network) and international TV Show Host known as 5TN (5 Technology News) , WHN (World Health News) and ITB (Idea to Business) broadcasting to more than 22 countries with 500 million viewers

Dr. Silay is currently working on establishing several VC and PE funds in healthcare and biotechnology. ICG (Istanbul Consulting Group) which was founded in 2013 and provided guidance to the Turkish ministry of health as part of a World Bank project. Yavuz is currently the Co-Founder of BioCube ?stanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of several healthcare companies . He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and director of Avcilar Hospital R&D Center, Chief Medical Officer of Lifematrix GmbH. Previously he worked as the Market Access & Health Policy Director for AIFD in Turkey.

Yavuz previously worked as the Vice President of IPSEN pharmaceutical and Director of Teva pharmaceutical in USA managing large clinical trials as well as Investigator Initiated Trials and developing relationships with Key Opinion Leaders. Previously, Yavuz was the Associate Director at KV Pharmaceuticals and Director in Clinical Development department at Forest Laboratories

Yavuz earned his MD from the Faculty of Medicine, University of Ankara in Ankara, Turkey. He completed a clinical internship at Baylor College of Medicine in Houston, followed by continued research training at The University of Texas MD Anderson Cancer Center in Houston. He recently completed his Executive MBA at the Olin Business School at Washington University in St. Louis. Yavuz currently resides with his wife Dr. Kamile Silay and their two daughters and one son in Ankara, Turkey.

Abstract

International TV Host Show in Healthcare, Technology and Business. Interaction with FDA. Development of generic and branded regulatory strategic plans for new product development, life cycle management of marketed products. Evaluation of potential products & in-licensing opportunities. Participate in all aspects of clinical development & study management, providing scientific, medical, and logistical direction and support to studies. Market Access to USA, Africa, Turkey & Europe. Clinical development in Medical Device & Pharmaceutical including Oncology/ CNS/Pain . Managing Phase 2-4 clinical trials.